The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

METHYLPHENIDATE INTERVIEWS IN PSYCHOTHERAPY

Published Online:https://doi.org/10.1176/ajp.117.6.549

1. The use of oral methylphenidate to potentiate interviews in 16 office psychotherapy patients was studied for a period of one year. Results indicate that in patients with fixed neurotic processes it can speed the therapeutic progress.

2. The drug gave no physical complications in 16 healthy subjects in doses that were two to four times that ordinarily prescribed. Dosages ranged from 40 to 80 mg. orally per dose.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.